Every year, our scientists and patient advisory group identify the studies and topics creating the most impact for people living with arthritis.
Uncover Our Focus for 2026Ongoing and completed studies across our full research portfolio, from prevention and treatment to care and health systems.
Explore Our ResearchMeet the scientists, clinicians, trainees, and patient advisory board members, driving discoveries
Meet Our TeamArthritis Research Canada's scientists and trainees regularly present new findings that advance arthritis prevention, treatment, and care.
Browse Conference AbstractsPeople living with arthritis guide our research priorities, shape study design, and ensure our work reflects real life.
Support Arthritis Research Canada with your time and skills. Whether you want to help at an event or host your own, there is a place for you here.
Living with arthritis? Explore open studies looking for participants and help shape the future of arthritis care.
Your experience with arthritis matters. Sharing it helps others feel less alone and brings the human reality of arthritis into everything we do.
Reason For Research
Multisystem Inflammatory Syndrome in Children (MIS-C) can occur weeks after a mild or even asymptomatic infection of COVID-19. During each new wave of COVID-19, previously healthy children are showing up at hospital in shock and heart failure, due to uncontrolled inflammation. This new syndrome closely resembles Kawasaki Disease (KD). KD is the result of an infection, which triggers an over active immune system, resulting in fever and inflammation of the blood vessels and coronary arteries. One in four children with MIS-C develops coronary artery inflammation. Health care teams need to rapidly recognize MIS-C, identify high risk children and control the life-threatening inflammation before it damages the child’s heart.
Our team has studied KD and has identified new medications for improved outcomes. The lessons learned from KD are transferrable to MIS-C to guide the development of new treatment approaches.
Execution of Research
In this study, we will use machine learning and artificial intelligence to rapidly diagnose MIS-C and predict which child will develop severe disease. This has worked previously with other diseases. The information will be shared with other countries to rapidly improve care for children affected by MIS-C.
Involvement
Our team includes doctors, scientists, and affected families working together to tackle this serious disease. We have a strong and deeply committed Canada-wide team, with the expertise and infrastructure already in place. We have key partners in Europe and the USA, using the same processes so that data can be shared more efficiently.